Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc logo
INO

Inovio Pharmaceuticals Inc (INO)

$1.825.2%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$1.75
Day's Range
$1.83
$1.38
52-Week Range
$9.96
1 month return1.7%
3 month return56.53%
1 year return80.3%
5 year return68.6%

Company Information

INOVIO is a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with HPV. INOVIO is the first and only company to have clinically demonstrated that a DNA medicine can be delivered directly into cells in the body via a proprietary smart device to produce a robust and tolerable immune response. INOVIO's lead immunotherapy candidate, VGX-3100, currently in Phase 3 trials for precancerous cervical dysplasia, cleared high-risk HPV-16 and/or HPV-18 in a Phase 2b clinical trial. High-risk HPV is responsible for 70% of cervical cancer, 91% of anal cancer, and 69% of vulvar cancer. Also in development are programs targeting HPV-related cancers and a rare HPV-related disease, recurrent respiratory papillomatosis (RRP); non-HPV-related cancers glioblastoma multiforme (GBM) and prostate cancer; as well as infectious disease DNA vaccine development programs in coronaviruses associated with COVID-19 diseases and MERS, Lassa fever, Ebola, and HIV. Partners and collaborators include Advaccine, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Advanced Research Projects Agency (DARPA)/Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND)/Department of Defense (DoD), HIV Vaccines Trial Network, International Vaccine Institute (IVI), Kaneka Eurogentec, Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Ology Bioservices, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron, Richter-Helm BioLogics, Thermo Fisher Scientific, University of Pennsylvania, Walter Reed Army Institute of Research, and The Wistar Institute. INOVIO also is a proud recipient of 2020 Women on Boards 'W' designation recognizing companies with more than 20% women on their board of directors.
OrganizationInovio Pharmaceuticals Inc
Employees262
CEOJong Kim
IndustryHealth Technology

Analyst Recommendation

based on 13 analysts ratings

Hold
46%
Buy
53%
Hold
0%
Sell

Based on 13 Wall street analysts offering stock ratings for Inovio Pharmaceuticals Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 526.01%

Current

$1.73

Target

$10.83

Recommendation Trend

Based on 13 analyst

Current1M Ago3M Ago
Buy
6
6
6
Hold
7
6
7
Sell
0
1
1
Consensus
HOLD
BUY
HOLD

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
614.3M
Book Value
1.84
Dividend Share
0.0
Dividend Yield
0.0
Earnings Share
-1.45
PEG Ratio
0.0
Wall Street Target Price
9.57

Valuation

Trailing PE0.0
Forward PE0.0
Price/Sales (ttm)
346.15
Price/Book (mrq)
1.59
Enterprise Value
268.2M
Enterprise Value/Revenue
151.13
Enterprise Value/Ebitda
0.0

Technicals

Beta
0.65
50 Day MA
3.32
200 Day MA
5.93

Institutional Holdings

State Street Corporation

10.16%

BlackRock Inc

7.97%

Vanguard Group Inc

4.91%

D. E. Shaw & Co LP

2.61%

JPMorgan Chase & Co

1.5%

Geode Capital Management, LLC

1.48%

Discover more

Frequently Asked Questions

What is Inovio Pharmaceuticals Inc share price today?

Can Indians buy Inovio Pharmaceuticals Inc shares?

How can I buy Inovio Pharmaceuticals Inc shares from India?

Can Fractional shares of Inovio Pharmaceuticals Inc be purchased?

What are the documents required to start investing in Inovio Pharmaceuticals Inc stocks?

What are today’s High and Low prices of Inovio Pharmaceuticals Inc?

What are today’s traded volumes of Inovio Pharmaceuticals Inc?

What is today’s market capitalisation of Inovio Pharmaceuticals Inc?

What is the 52 Week High and Low Range of Inovio Pharmaceuticals Inc?

How much percentage Inovio Pharmaceuticals Inc is down from its 52 Week High?

How much percentage Inovio Pharmaceuticals Inc is up from its 52 Week low?

What are the historical returns of Inovio Pharmaceuticals Inc?

Who is the Chief Executive Officer (CEO) of Inovio Pharmaceuticals Inc?